Raras
Buscar doenças, sintomas, genes...
Síndrome de anomalia cardíaca congênita-dismorfia facial-transtorno do desenvolvimento TMEM94-associada
ORPHA:562569CID-10 · Q87.8CID-11 · LD2F.1YOMIM 618316DOENÇA RARA

Distúrbio genético raro do desenvolvimento neurológico caracterizado por atraso global no desenvolvimento, defeitos cardíacos congênitos, hipertricose generalizada e características faciais dismórficas, mais comumente face triangular, sobrancelhas grossas e arqueadas, olhos bem espaçados, orelhas baixas giradas posteriormente, ponte nasal deprimida, raiz e ponta nasal larga e queixo pontudo.

Mantido por Agente Raras·Colaborar como especialista →

Introdução

O que você precisa saber de cara

📋

Distúrbio genético raro do desenvolvimento neurológico caracterizado por atraso global no desenvolvimento, defeitos cardíacos congênitos, hipertricose generalizada e características faciais dismórficas, mais comumente face triangular, sobrancelhas grossas e arqueadas, olhos bem espaçados, orelhas baixas giradas posteriormente, ponte nasal deprimida, raiz e ponta nasal larga e queixo pontudo.

Escala de raridade

CLASSIFICAÇÃO ORPHANET · BRASIL 2024
<1 / 1 000 000
Ultra-rara
<1/50k
Muito rara
1/20k
Rara
1/10k
Pouco freq.
1/5k
Incomum
1/2k
Prevalência
0.0
Worldwide
Casos conhecidos
10
pacientes catalogados
Início
Antenatal
+ neonatal
🏥
SUS: Cobertura mínimaScore: 35%
Centros em: PA, PR, SC, RS, ES +10CID-10: Q87.8
🇧🇷Dados SUS / DATASUS
PROCEDIMENTOS SIGTAP (5)
0202010503
Cariótipo — bandas G, Q ou Rgenetic_test
0202010600
Pesquisa de microdeleções/microduplicações por FISHlab_test
0202010694
Sequenciamento completo do exoma (WES)rehabilitation
0202010260
Dosagem de alfa-fetoproteína
0301070040
Atendimento em reabilitação — doenças raras
Você se identifica com essa condição?
O Raras está aqui pra te apoiar — com ou sem diagnóstico

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Entender a doença

Do básico ao detalhe, leia no seu ritmo

Preparando trilha educativa...

Sinais e sintomas

O que aparece no corpo e com que frequência cada sintoma acontece

Partes do corpo afetadas

😀
Face
10 sintomas
🦴
Ossos e articulações
7 sintomas
🧠
Neurológico
5 sintomas
❤️
Coração
4 sintomas
👂
Ouvidos
4 sintomas
👁️
Olhos
4 sintomas

+ 21 sintomas em outras categorias

Características mais comuns

100%prev.
HP:0003577
Frequência: 10/10
100%prev.
Lóbulo da orelha grande
Frequência: 10/10
100%prev.
Dificuldade específica de aprendizagem
Frequência: 10/10
100%prev.
Face triangular
Frequência: 10/10
100%prev.
Atraso no desenvolvimento da fala e da linguagem
Frequência: 10/10
100%prev.
Queixo pontudo
Frequência: 10/10
60sintomas
Muito frequente (13)
Frequente (7)
Ocasional (28)
Sem dados (12)

Os sintomas variam de pessoa para pessoa. Abaixo estão as 60 características clínicas mais associadas, ordenadas por frequência.

HP:0003577
Frequência: 10/10100%
Lóbulo da orelha grandeLarge earlobe
Frequência: 10/10100%
Dificuldade específica de aprendizagemSpecific learning disability
Frequência: 10/10100%
Face triangularTriangular face
Frequência: 10/10100%
Atraso no desenvolvimento da fala e da linguagemDelayed speech and language development
Frequência: 10/10100%

Linha do tempo da pesquisa

Publicações por ano — veja quando o interesse científico cresceu
Anos de pesquisa1desde 2026
Últimos 10 anos200publicações
Pico2025124 papers
Linha do tempo
2026Hoje · 2026📈 2025Ano de pico
Publicações por ano (últimos 10 anos)

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Genética e causas

O que está alterado no DNA e como passa nas famílias

Genes associados

1 gene identificado com associação a esta condição. Padrão de herança: Autosomal recessive.

TMEM94Transmembrane protein 94Disease-causing germline mutation(s) (loss of function) inTolerante
FUNÇÃO

Could function in the uptake of Mg(2+) from the cytosol into the endoplasmic reticulum and regulate intracellular Mg(2+) homeostasis

LOCALIZAÇÃO

Endoplasmic reticulum membrane

MECANISMO DE DOENÇA

Intellectual developmental disorder with cardiac defects and dysmorphic facies

An autosomal recessive neurodevelopmental disorder characterized by global developmental delay, intellectual disability, congenital heart malformations, and facial dysmorphism. Dysmorphic features include triangular face, deep set eyes, broad nasal root and tip and anteverted nostrils, thick arched eye brows, hypertrichosis, pointed chin, and hypertelorism.

EXPRESSÃO TECIDUAL(Ubíquo)
Cerebelo
94.0 TPM
Cérebro - Hemisfério cerebelar
74.5 TPM
Pituitária
66.7 TPM
Tireoide
63.7 TPM
Ovário
61.0 TPM
INTERAÇÕES PROTEICAS (2)
OUTRAS DOENÇAS (1)
intellectual developmental disorder with cardiac defects and dysmorphic facies
HGNC:28983UniProt:Q12767

Variantes genéticas (ClinVar)

56 variantes patogênicas registradas no ClinVar.

🧬 TMEM94: NM_014738.6(TMEM94):c.611A>G (p.Lys204Arg) ()
🧬 TMEM94: NM_014738.6(TMEM94):c.2364C>G (p.Ile788Met) ()
🧬 TMEM94: NM_014738.6(TMEM94):c.1535C>T (p.Pro512Leu) ()
🧬 TMEM94: NM_014738.6(TMEM94):c.1396C>T (p.Arg466Ter) ()
🧬 TMEM94: NM_014738.6(TMEM94):c.3244-61C>G ()
Ver todas no ClinVar

Diagnóstico

Os sinais que médicos procuram e os exames que confirmam

Carregando...

Tratamento e manejo

Remédios, cuidados de apoio e o que precisa acompanhar

Carregando informações de tratamento...

Onde tratar no SUS

Hospitais de referência no Brasil e o protocolo oficial do SUS (PCDT)

🇧🇷 Atendimento SUS — Síndrome de anomalia cardíaca congênita-dismorfia facial-transtorno do desenvolvimento TMEM94-associada

Centros de Referência SUS

37 centros habilitados pelo SUS para Síndrome de anomalia cardíaca congênita-dismorfia facial-transtorno do desenvolvimento TMEM94-associada

Centros para Síndrome de anomalia cardíaca congênita-dismorfia facial-transtorno do desenvolvimento TMEM94-associada

Detalhes dos centros

Hospital Universitário Prof. Edgard Santos (HUPES)

R. Dr. Augusto Viana, s/n - Canela, Salvador - BA, 40110-060 · CNES 0003808

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do Metabolismo

Hospital Infantil Albert Sabin

R. Tertuliano Sales, 544 - Vila União, Fortaleza - CE, 60410-794 · CNES 2407876

Serviço de Referência

Rota
Anomalias CongênitasDeficiência Intelectual

Hospital Infantil Albert Sabin

R. Tertuliano Sales, 544 - Vila União, Fortaleza - CE, 60410-794 · CNES 2407876

Serviço de Referência

Rota
Anomalias CongênitasDeficiência Intelectual

Hospital de Apoio de Brasília (HAB)

AENW 3 Lote A Setor Noroeste - Plano Piloto, Brasília - DF, 70684-831 · CNES 0010456

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do MetabolismoDeficiência Intelectual

Hospital de Apoio de Brasília (HAB)

AENW 3 Lote A Setor Noroeste - Plano Piloto, Brasília - DF, 70684-831 · CNES 0010456

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do MetabolismoDeficiência Intelectual

Hospital Estadual Infantil e Maternidade Alzir Bernardino Alves (HIABA)

Av. Min. Salgado Filho, 918 - Soteco, Vila Velha - ES, 29106-010 · CNES 6631207

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do MetabolismoDeficiência Intelectual

Hospital Estadual Infantil e Maternidade Alzir Bernardino Alves (HIABA)

Av. Min. Salgado Filho, 918 - Soteco, Vila Velha - ES, 29106-010 · CNES 6631207

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do MetabolismoDeficiência Intelectual

Hospital das Clínicas da UFG

Rua 235 QD. 68 Lote Área, Nº 285, s/nº - Setor Leste Universitário, Goiânia - GO, 74605-050 · CNES 2338424

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do Metabolismo

Hospital Universitário da UFJF

R. Catulo Breviglieri, Bairro - s/n - Santa Catarina, Juiz de Fora - MG, 36036-110 · CNES 2297442

Atenção Especializada

Rota
Anomalias Congênitas

Hospital das Clínicas da UFMG

Av. Prof. Alfredo Balena, 110 - Santa Efigênia, Belo Horizonte - MG, 30130-100 · CNES 2280167

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do MetabolismoDeficiência Intelectual

Hospital das Clínicas da UFMG

Av. Prof. Alfredo Balena, 110 - Santa Efigênia, Belo Horizonte - MG, 30130-100 · CNES 2280167

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do MetabolismoDeficiência Intelectual

Hospital Universitário Julio Müller (HUJM)

R. Luis Philippe Pereira Leite, s/n - Alvorada, Cuiabá - MT, 78048-902 · CNES 2726092

Atenção Especializada

Rota
Anomalias Congênitas

Hospital Universitário João de Barros Barreto

R. dos Mundurucus, 4487 - Guamá, Belém - PA, 66073-000 · CNES 2337878

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do MetabolismoDeficiência Intelectual

Hospital Universitário João de Barros Barreto

R. dos Mundurucus, 4487 - Guamá, Belém - PA, 66073-000 · CNES 2337878

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do MetabolismoDeficiência Intelectual

Hospital Universitário Lauro Wanderley (HULW)

R. Tabeliao Estanislau Eloy, 585 - Castelo Branco, João Pessoa - PB, 58050-585 · CNES 0002470

Atenção Especializada

Rota
Anomalias Congênitas

Instituto de Medicina Integral Prof. Fernando Figueira (IMIP)

R. dos Coelhos, 300 - Boa Vista, Recife - PE, 50070-902 · CNES 0000647

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do MetabolismoDeficiência Intelectual

Instituto de Medicina Integral Prof. Fernando Figueira (IMIP)

R. dos Coelhos, 300 - Boa Vista, Recife - PE, 50070-902 · CNES 0000647

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do MetabolismoDeficiência Intelectual

Hospital Pequeno Príncipe

R. Des. Motta, 1070 - Água Verde, Curitiba - PR, 80250-060 · CNES 3143805

Serviço de Referência

Rota
Anomalias CongênitasDeficiência Intelectual

Hospital Pequeno Príncipe

R. Des. Motta, 1070 - Água Verde, Curitiba - PR, 80250-060 · CNES 3143805

Serviço de Referência

Rota
Anomalias CongênitasDeficiência Intelectual

Hospital Universitário Regional de Maringá (HUM)

Av. Mandacaru, 1590 - Parque das Laranjeiras, Maringá - PR, 87083-240 · CNES 2216108

Atenção Especializada

Rota
Anomalias Congênitas

Hospital de Clínicas da UFPR

R. Gen. Carneiro, 181 - Alto da Glória, Curitiba - PR, 80060-900 · CNES 2364980

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do MetabolismoDeficiência Intelectual

Hospital de Clínicas da UFPR

R. Gen. Carneiro, 181 - Alto da Glória, Curitiba - PR, 80060-900 · CNES 2364980

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do MetabolismoDeficiência Intelectual

Hospital Universitário Pedro Ernesto (HUPE-UERJ)

Blvd. 28 de Setembro, 77 - Vila Isabel, Rio de Janeiro - RJ, 20551-030 · CNES 2280221

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do Metabolismo

Instituto Nacional de Saúde da Mulher, da Criança e do Adolescente Fernandes Figueira (IFF/Fiocruz)

Av. Rui Barbosa, 716 - Flamengo, Rio de Janeiro - RJ, 22250-020 · CNES 2269988

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do MetabolismoDeficiência Intelectual

Instituto Nacional de Saúde da Mulher, da Criança e do Adolescente Fernandes Figueira (IFF/Fiocruz)

Av. Rui Barbosa, 716 - Flamengo, Rio de Janeiro - RJ, 22250-020 · CNES 2269988

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do MetabolismoDeficiência Intelectual

Hospital São Lucas da PUCRS

Av. Ipiranga, 6690 - Jardim Botânico, Porto Alegre - RS, 90610-000 · CNES 2232928

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do Metabolismo

Hospital de Clínicas de Porto Alegre (HCPA)

Rua Ramiro Barcelos, 2350 Bloco A - Av. Protásio Alves, 211 - Bloco B e C - Santa Cecília, Porto Alegre - RS, 90035-903 · CNES 2237601

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do MetabolismoDeficiência Intelectual

Hospital de Clínicas de Porto Alegre (HCPA)

Rua Ramiro Barcelos, 2350 Bloco A - Av. Protásio Alves, 211 - Bloco B e C - Santa Cecília, Porto Alegre - RS, 90035-903 · CNES 2237601

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do MetabolismoDeficiência Intelectual

Hospital Universitário da UFSC (HU-UFSC)

R. Profa. Maria Flora Pausewang - Trindade, Florianópolis - SC, 88036-800 · CNES 2560356

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do Metabolismo

Hospital das Clínicas da FMUSP

R. Dr. Ovídio Pires de Campos, 225 - Cerqueira César, São Paulo - SP, 05403-010 · CNES 2077485

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do MetabolismoDeficiência Intelectual

Hospital das Clínicas da FMUSP

R. Dr. Ovídio Pires de Campos, 225 - Cerqueira César, São Paulo - SP, 05403-010 · CNES 2077485

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do MetabolismoDeficiência Intelectual

Hospital de Base de São José do Rio Preto

Av. Brg. Faria Lima, 5544 - Vila Sao Jose, São José do Rio Preto - SP, 15090-000 · CNES 2079798

Atenção Especializada

Rota
Anomalias Congênitas

Hospital de Clínicas da UNICAMP

R. Vital Brasil, 251 - Cidade Universitária, Campinas - SP, 13083-888 · CNES 2748223

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do MetabolismoDeficiência Intelectual

Hospital de Clínicas da UNICAMP

R. Vital Brasil, 251 - Cidade Universitária, Campinas - SP, 13083-888 · CNES 2748223

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do MetabolismoDeficiência Intelectual

Hospital de Clínicas de Ribeirão Preto (HCRP-USP)

R. Ten. Catão Roxo, 3900 - Vila Monte Alegre, Ribeirão Preto - SP, 14015-010 · CNES 2082187

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do MetabolismoDeficiência Intelectual

Hospital de Clínicas de Ribeirão Preto (HCRP-USP)

R. Ten. Catão Roxo, 3900 - Vila Monte Alegre, Ribeirão Preto - SP, 14015-010 · CNES 2082187

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do MetabolismoDeficiência Intelectual

UNIFESP / Hospital São Paulo

R. Napoleão de Barros, 715 - Vila Clementino, São Paulo - SP, 04024-002 · CNES 2688689

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do Metabolismo
Sobre os centros SUS: Estes centros são habilitados pelo Ministério da Saúde como Serviços de Referência em Doenças Raras ou Serviços de Atenção Especializada. O atendimento é pelo SUS, com encaminhamento da rede de atenção básica.

Dados de DATASUS/CNES, SBGM, ABNeuro e Ministério da Saúde. Sempre confirme a disponibilidade diretamente com o estabelecimento.

Pesquisa ativa

Ensaios clínicos abertos e novidades científicas recentes

Pesquisa e ensaios clínicos

Nenhum ensaio clínico registrado para esta condição.

🧪 Está conduzindo uma pesquisa?
Divulgue para pacientes e familiares que acompanham esta doença.
Divulgar pesquisa →

Publicações mais relevantes

Timeline de publicações
0 papers (10 anos)
#1

Inferior wall ST-elevation myocardial infarction in a patient with a single coronary artery from the right coronary cusp trifurcating into the left anterior descending, left circumflex, and right coronary arteries: a rare coronary anomaly, case report.

European heart journal. Case reports2026 Mar

Abnormal origin of a coronary artery is a rare congenital condition that can significantly affect clinical outcomes especially when associated with acute coronary syndromes. Among these, the presence of a single coronary artery trifurcating from the right coronary cusp into all major coronary branches is exceptionally rare and poorly represented in the literature. A 35-year-old man presented with an inferior ST-elevation myocardial infarction. Emergency angiography revealed a single coronary artery arising from the right coronary cusp. The culprit was the right coronary artery. It was effectively treated with intravascular-guided percutaneous coronary intervention, and the remaining coronaries demonstrated normal flow, as shown in subsequent imaging. The patient recovered uneventfully, rehabilitated without complications. He was discharged on guideline directed medical therapy. Although the anomalous coronary anatomy was not the direct cause of infarction, it introduced significant procedural challenges that could have delayed or compromised revascularization. Our case highlights the importance of recognizing and anticipating coronary anomalies in acute settings. Multimodality imaging and anatomical classification systems help provide timely diagnosis, procedural planning, and risk assessment from a long-term perspective.

#2

Acute Coronary Syndromes in Premenopausal Women: A Scientific Statement From the American Heart Association.

Circulation2026 Feb 17

Premenopausal women presenting with acute coronary syndrome (ACS) are a unique and often underrecognized patient population. Although they are traditionally considered at lower cardiovascular risk than other groups, we have begun to appreciate the potential risk for ACS in this younger subset of women. Whereas atherosclerotic disease (obstructive or nonobstructive) accounts for most presentations, a substantial number are attributable to nonatherosclerotic causes, including spontaneous coronary artery dissection, epicardial coronary artery spasm, and coronary embolism. A major challenge at present is the lack of specific data and evidence for the diagnosis and management of these women. Unfortunately, as a result of several factors, diagnostic delays, misclassification, and mistreatment appear to be more frequent than for other patient groups. Of great concern, younger women less often receive guideline-directed therapies after ACS, and younger women with ACS have been shown to have worse outcomes than young men with ACS. Management should be tailored to the unique pathophysiology in premenopausal women, emphasizing early diagnosis, a low threshold for invasive angiography if appropriate, and special consideration in the pregnant patient. Secondary prevention must address traditional cardiovascular and disease-specific risk factors, with consideration of current or future pregnancies and lactation. Participation in cardiac rehabilitation is associated with improved outcomes and must be strongly encouraged, whereas attention to potential post-ACS depression and anxiety is an important aspect of holistic care. Increased patient and health care professional awareness and improved representation in research are critical to closing the knowledge and outcome gaps in premenopausal women with ACS.

#3

Expanding the Phenotypic Spectrum Associated With Loss-of-Function SMARCA4 Variants to Eye Developmental Anomalies.

Clinical genetics2026 Jan 22

The SMARCA4 gene encodes a catalytic subunit of the BRG1/BRM-associated factor complex, which regulates gene expression through chromatin remodeling. Heterozygous missense variants in this gene have been linked to Coffin-Siris syndrome, characterized by intellectual development disorder and various congenital anomalies (distinctive facial features, hypoplastic fifth digits, and malformations of the heart and central nervous system), but it is not typically associated with structural eye anomalies. Truncating variants in SMARCA4 have been associated with rhabdoid tumors predisposition syndrome, a group of rare and aggressive tumors occurring predominantly in infancy. Through pangenomic analyses (whole-exome or whole-genome sequencing), we identified loss-of-function variants in SMARCA4 in three unrelated individuals with microphthalmia and/or coloboma. None of these individuals had a history of rhabdoid tumors; however, a regular oncological follow-up was established following the SMARCA4 variant identification. Systemic features observed in these individuals consisted of developmental delay and brain anomalies. However, their clinical presentation does not align with classic features of Coffin-Siris syndrome. Although eye development anomalies have occasionally been reported in individuals with a pathogenic variant in SMARCA4, no clear association has been established to date. The description of these three new individuals provides further evidence supporting the role of SMARCA4 in eye development and its likely involvement in structural eye malformations. Fanconi anemia (FA) is characterized by physical abnormalities, bone marrow failure, and increased risk for malignancy. Characteristic physical abnormalities, present in approximately 75% of affected individuals, include one or more of the following: growth deficiency, abnormal skin pigmentation, skeletal malformations of the upper and/or lower limbs, microcephaly, genitourinary tract anomalies, and ocular manifestations. Endocrine disorders (hypothyroidism, diabetes / impaired glucose tolerance), hearing loss, developmental delay, congenital heart defects, and gastrointestinal malformations are also more common in those with FA. Progressive bone marrow failure with pancytopenia typically presents in the first decade, often initially with thrombocytopenia or leukopenia. The incidence of myelodysplastic syndrome (MDS) or acute myeloid leukemia (AML) is 35% by age 40 years. Solid tumors – particularly of the head and neck, skin, and genitourinary tract – are more common in individuals with FA. The diagnosis of FA is established in a proband with increased chromosome breakage and radial forms on cytogenetic testing of lymphocytes with diepoxybutane (DEB) and mitomycin C (MMC) and/or one of the following identified on molecular genetic testing: biallelic pathogenic variants in one of the 21 genes known to cause autosomal recessive FA; a heterozygous pathogenic variant in RAD51 known to cause autosomal dominant FA; or a hemizygous pathogenic variant in FANCB known to cause X-linked FA. Targeted therapies: Oral androgens (e.g., oxymetholone, danazol) may transiently improve red blood cell and platelet counts in approximately 50% of individuals with FA. Granulocyte colony-stimulating factor improves the neutrophil count in some individuals. Hematopoietic stem cell transplantation (HSCT) is the only curative therapy for the hematologic manifestations of FA, but the non-hematologic manifestations remain, including a high risk for solid tumors, which may be increased following HSCT. All these therapies have potential significant toxicity. Treatment of manifestations: Treatment of growth deficiency, limb anomalies, other orthopedic manifestations, kidney malformations, genital anomalies, hypothyroidism, diabetes, ocular anomalies, hearing loss, and cardiac anomalies as recommended by the subspecialty care provider. Early intervention for developmental delays; individualized education plan for school-age children; speech, occupational, and physical therapy as needed. Supplemental feeding as needed by nasogastric tube or gastrostomy tube. Treatment of bone marrow failure / MDS / AML through a center with experience in FA; early detection and surgical removal for solid tumors; human papilloma virus vaccination to reduce the risk for gynecologic cancer in females and reduce the risk of oral cancer in all individuals; liberal use of sunscreen and rash guards; treatment of skin cancer per dermatologist in coordination with multidisciplinary experts in FA; social work and care coordination as needed. Surveillance: Clinical assessment of growth, feeding, nutrition, spine, and ocular issues at each visit throughout childhood. Annual ophthalmology examination; assessment of pubertal stage and hormone levels at puberty and every two years until puberty is complete; annual evaluation with endocrinologist including TSH, free T4, 25-hydroxyvitamin D, two-hour glucose tolerance testing, and measurement of insulin concentration; follow-up hearing evaluation if exposed to ototoxic drugs; annual developmental assessment throughout childhood; blood counts every three to four months or as needed; bone marrow aspirate and biopsy to evaluate morphology and cellularity; FISH and cytogenetics to evaluate for emergence of a malignant clone at least annually after age two years; liver function tests every three to six months and liver ultrasound every six to twelve months in those receiving androgen therapy; gynecologic assessment for genital lesions annually beginning at age 13 years; vulvo-vaginal examinations and Pap smear annually beginning at age 18 years or with onset of sexual activity; oral examinations for tumors every six months beginning at age nine to ten years; annual nasolaryngoscopy beginning at age ten years; dermatology evaluation every six to 12 months; annual abdominal ultrasound and brain MRI in those with BRCA2-related FA. Additional cancer surveillance for individuals with BRCA1-, BRCA2-, BRIP1-, PALB2-, and RAD51C-related FA per National Comprehensive Cancer Network (NCCN) screening guidelines. Agents/circumstances to avoid: Transfusions of red blood cells or platelets for persons who are candidates for HSCT; family members as blood donors if HSCT is being considered; blood products that are not filtered (leuko-depleted) or irradiated; toxic agents that have been implicated in tumorigenesis; excessive sun exposure; unsafe sex practices, which increase the risk of HPV-associated malignancy. Radiographic studies solely for the purpose of surveillance (i.e., in the absence of clinical indications) should be minimized. Evaluation of relatives at risk: Molecular genetic testing (if the family-specific pathogenic variant[s] are known) or DEB/MMC cytogenetic testing of all sibs of a proband (and all at-risk family members of an individual with autosomal dominant [RAD51-related] or X-linked [FANCB-related] FA) for early diagnosis, treatment, and monitoring for physical abnormalities, bone marrow failure, and related cancers. FA is inherited in an autosomal recessive manner, an autosomal dominant manner (RAD51-related FA), or an X-linked manner (FANCB-related FA). Autosomal recessive FA: If both parents are known to be heterozygous for an autosomal recessive FA-related pathogenic variant, each sib of an affected individual has at conception a 25% chance of inheriting both pathogenic variants and being affected, a 50% chance of inheriting one pathogenic variant and being heterozygous, and a 25% chance of inheriting neither of the familial FA-related pathogenic variants. Heterozygotes are not at risk for autosomal recessive FA. However, heterozygous pathogenic variants in a subset of FA-related genes (e.g., BRCA1, BRCA2, PALB2, BRIP1, and RAD51C) are associated with an increased risk for breast and other cancers. Heterozygote testing for at-risk relatives requires prior identification of the FA-related pathogenic variants in the family. Autosomal dominant FA: Given that all probands with RAD51-related FA reported to date whose parents have undergone molecular genetic testing have the disorder as a result of a de novo RAD51 pathogenic variant, the risk to other family members is presumed to be low. X-linked FA: The risk to sibs of a male proband depends on the genetic status of the mother. If the mother of the proband has a FANCB pathogenic variant, the chance of the mother transmitting it in each pregnancy is 50%. Male sibs who inherit the pathogenic variant will be affected. Female sibs who inherit the pathogenic variant will be heterozygotes and will usually not be affected. Heterozygote testing for at-risk female relatives requires prior identification of the FANCB pathogenic variant in the family. Molecular genetic prenatal testing and preimplantation genetic testing are possible if the pathogenic variant(s) in the family are known.

#4

Generation of three induced pluripotent stem cell clones from a functional single ventricle patient carrying the BRAF c.1897 T > C variant.

Stem cell research2026 Feb

Cardiofaciocutaneous syndrome is a genetic disorder characterized by congenital heart disease, developmental delays and ectodermal abnormalities. Cardiofaciocutaneous syndrome is caused by pathogenic variants in the genes of the RAS/MAPK pathway, particularly BRAF. However, the mechanism by which congenital heart defects arise in RASopathy patients is still poorly understood. Therefore, using non-integrating episomal vectors, we generated three hiPSC clones from peripheral blood mononuclear cells from a 33-year old male carrying a c.1897 T > C missense variant in the BRAF gene, who was born with pulmonary stenosis, tricuspid atresia and hypoplastic right ventricle, consistent with a functional single ventricle. Noonan syndrome (NS) is characterized by characteristic facies, short stature, congenital heart defect, and developmental delay of variable degree. Other findings can include broad or webbed neck, unusual chest shape with superior pectus carinatum and inferior pectus excavatum, cryptorchidism, varied coagulation defects, lymphatic dysplasias, and ocular abnormalities. Although birth length is usually normal, final adult height approaches the lower limit of normal. Congenital heart disease occurs in 50%-80% of individuals. Pulmonary valve stenosis, often with dysplasia, is the most common heart defect and is found in 20%-50% of individuals. Hypertrophic cardiomyopathy, found in 20%-30% of individuals, may be present at birth or develop in infancy or childhood. Other structural defects include atrial and ventricular septal defects, branch pulmonary artery stenosis, and tetralogy of Fallot. Up to one fourth of affected individuals have mild intellectual disability, and language impairments in general are more common in NS than in the general population. The diagnosis of Noonan is established in a proband with suggestive findings and a heterozygous pathogenic variant in BRAF, KRAS, MAP2K1, MRAS, NRAS, PTPN11, RAF1, RASA2, RIT1, RRAS2, SOS1, or SOS2 or either a heterozygous variant or biallelic pathogenic variants in LZTR1 identified by molecular genetic testing. Several additional genes associated with a Noonan syndrome-like phenotype in fewer than ten individuals have been identified. Treatment of manifestations: Cardiovascular anomalies in NS are usually treated as in the general population. Developmental disabilities are addressed by early intervention programs and individualized education strategies. Treatment for serious bleeding is guided by knowledge of the specific factor deficiency or platelet aggregation anomaly. Growth hormone (GH) treatment increases growth velocity. Standard treatment for juvenile myelomonocytic leukemia (JMML) and other malignancies, feeding difficulties, ADHD, behavioral problems, cryptorchidism in males, renal anomalies / hydronephrosis, strabismus, hearing loss, and Chiari malformation. Surveillance: At each visit: measurement of growth parameters; evaluation of nutritional status in infants and toddlers; monitor for evidence of new neurologic manifestations (chronic headache, neck pain, changes in tone, dizziness, or obstructive sleep apnea); monitor developmental progress; assessment of behavioral issues, as age appropriate; skin examination. Annually in childhood or as clinically indicated: ophthalmology and audiology evaluations. In children age <5 years: if initial cardiac evaluation is normal, at least annual cardiac evaluations until age 5 years. In children age >5 years through adulthood, cardiac evaluation at least every 5 years, or as clinically indicated. Prior to any surgical procedure or in those with clinical bleeding: assessment of bleeding history, CBC with differential, and consideration of measurement of coagulation factors. For those with pathogenic PTPN11 or KRAS variants: consider physical examination with assessment of spleen size & CBC every 3-6 months until age 5 years to assess for concerns about JMML/malignancy. Agents/circumstances to avoid: Aspirin therapy should be avoided because it may exacerbate a bleeding diathesis. Pregnancy management: Consider referral to an adult congenital heart program for peripartum evaluation and management; consider a hematology referral if the affected pregnant woman has a history of bleeding abnormalities and/or has not undergone previous screening for coagulopathy. NS is most often inherited in an autosomal dominant manner. While many individuals with autosomal dominant NS have a de novo pathogenic variant, an affected parent is recognized in 30%-75% of families. The risk to sibs of a proband with autosomal dominant NS depends on the genetic status of the parents: if a parent is affected, the risk is 50%; when the parents are clinically unaffected, the risk to the sibs of a proband appears to be low (<1%). Each child of an individual with autosomal dominant NS has a 50% chance of inheriting the pathogenic variant. NS caused by pathogenic variants in LZTR1 can be inherited in either an autosomal dominant or an autosomal recessive manner. The parents of an individual with autosomal recessive NS are typically heterozygotes (i.e., have one LZTR1 pathogenic variant), and may either be asymptomatic or have mild features of NS. If both parents are heterozygous for one LZTR1 pathogenic variant, each sib of an affected individual has at conception a 25% chance of being affected, a 50% chance of having one LZTR1 pathogenic variant (which can be associated with mild NS features), and a 25% chance of being unaffected and not a carrier. Prenatal testing and preimplantation genetic testing are possible if the NS-related pathogenic variant(s) have been identified in an affected family member.

#5

De novo truncating variant in the FBRSL1 gene caused neurodevelopmental disorders, epilepsy, congenital heart disease, and facial dysmorphism.

Experimental neurology2026 Feb

This study aims to investigate the causative role of FBRSL1, a paralog of the established neurodevelopmental disorder (NDD) gene AUTS2, in developmental disorders. Whole-exome sequencing was conducted to identify possible pathogenic variants. Functional studies were conducted in zebrafish models with fbrsl1 knockdown to investigate the gene-disease association. The role of FBRSL1 in development was studied via single-cell RNA sequencing and spatio-temporal expression. We identified a de novo FBRSL1 variant p.Ala128Cysfs*5 in a patient with neurodevelopmental delay, epilepsy, congenital heart disease, and facial dysmorphism. Further analysis of four patients with FBRSL1 variants revealed an emerging syndromic NDD, characterized by microcephaly, global developmental delay, autism, facial dysmorphism, and skeletal contractures. Zebrafish knockdown models recapitulated neurodevelopmental abnormalities, epileptiform discharges, and cardiac dysfunction, consistent with the patient's phenotypes. FBRSL1 is highly expressed in the developing brain and heart, potentially explaining its multisystem phenotypes. Single-cell RNA sequencing revealed a high expression of FBRSL1 in neural progenitors of 1-month-old organoids, suggesting its vital role in neurodevelopment. This study suggested FBRSL1 as a causative gene of syndromic developmental disorders with multisystem involvement, bridged gaps in understanding shared genetic mechanisms underlying multisystem developmental pathologies, and offered novel avenues for precision medicine approaches.

Publicações recentes

Ver todas no PubMed

📚 EuropePMCmostrando 200

2026

Inferior wall ST-elevation myocardial infarction in a patient with a single coronary artery from the right coronary cusp trifurcating into the left anterior descending, left circumflex, and right coronary arteries: a rare coronary anomaly, case report.

European heart journal. Case reports
2026

Complex Genetic Architecture in RASopathies: Constitutional PTPN11 and Mosaic RIT1 Pathogenic Variants Underlying Severe Noonan Syndrome With Adult-Onset Acute Myeloid Leukemia.

American journal of medical genetics. Part A
2026

KCNH2 Duplication Variant (c.2164_2181dup) Associated with Sudden Cardiac Death in a Family with Congenital Long QT Syndrome.

The Canadian journal of cardiology
2026

Identification of a novel NSD1 pathogenic variant in a Senegalese child with Sotos syndrome.

Journal, genetic engineering &amp; biotechnology
2026

Optimizing Diagnostic Accuracy of Clinical Red Flags in RASopathies.

American journal of medical genetics. Part A
2026

Organ-Specific Histopathological Effects of Prenatal Alcohol Exposure: A Narrative Review.

Congenital anomalies
2026

Clinical Presentation and Long-Term Outcomes of Prune Belly Syndrome in a Tertiary Hospital.

Archivos espanoles de urologia
2025

Challenges in managing pediatric heart failure, especially in resource-limited settings.

Annals of pediatric cardiology
2026

Expansion of the 3MC Syndrome Spectrum: Novel COLEC10 Variants and a MASP1 Exon-Level Deletion.

American journal of medical genetics. Part A
2026

Fetal Rapid Eye Movement Sleep Dysfunction as a Potential Early Indicator for NALCN-Related CLIFAHDD Syndrome: A Case Report.

Prenatal diagnosis
2025

[Analysis of a child with You-Hoover-Fong syndrome due to compound heterozygous variants of the TELO2 gene and a literature review].

Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics
2025

[Van Wyk-Grombach syndrome as a result of late diagnosis of autoimmune thyroiditis (ait) in a patient with chromosome 22 deletion syndrome. Description of the clinical case and a brief review of the literature].

Problemy endokrinologii
2026

Acute Coronary Syndromes in Premenopausal Women: A Scientific Statement From the American Heart Association.

Circulation
2026

A Patient With Intellectual Disability, Agenesis of Corpus Callosum, and Congenital Heart Disease Associated With Chromosome 10p11.2 Microdeletion.

American journal of medical genetics. Part A
2026

Influence of Technical Performance Score on Outcomes After Tetralogy of Fallot Repair in a Low-Middle-Income Country.

World journal for pediatric &amp; congenital heart surgery
2025

Prevention of Respiratory Infections in Children with Congenital Heart Disease: Current Evidence and Clinical Strategies.

Vaccines
2025

A Systematic Review Illustrates the Expanding Clinical and Molecular Landscape of Helsmoortel-Van der Aa Syndrome.

Brain sciences
2025

Platypnea-Orthodeoxia Syndrome Revealing an Undiagnosed Patent Foramen Ovale: A Case Report.

Cureus
2026

Lutembacher's syndrome presenting in the third trimester: a multidisciplinary challenge in a low-resource setting.

BMC cardiovascular disorders
2026

Expanding the Phenotypic Spectrum Associated With Loss-of-Function SMARCA4 Variants to Eye Developmental Anomalies.

Clinical genetics
2026

Management of hypoparathyroidism during pregnancy following late maternal diagnosis of DiGeorge syndrome: a case report.

Journal of medical case reports
2026

Genotype-Phenotype Correlations in Klinefelter and Turner Syndrome: A Decade of Sex Chromosome Aneuploidy Data From a Single Academic Medical Center.

Molecular genetics &amp; genomic medicine
2026

[National protocol for the diagnosis and management of Axenfeld-Rieger syndrome: Summary for the primary care physician].

Journal francais d'ophtalmologie
2025

Case Report: The case of atypical OAPS complicated by positive anti-SSA and anti-SSB antibodies.

Frontiers in immunology
2025

Challenges in Managing a Congenital Strangulated Bochdalek Hernia in an Older Female Patient in a Low-Income Country: A Case Report.

Journal of abdominal wall surgery : JAWS
2025

Early onset Arboleda-Tham syndrome due to KAT6A variants: Case report.

Frontiers in genetics
2025

Prenatally Diagnosed De Novo Interstitial Duplication in 2p21p24.3 with Unique Manifestations: Case Report.

Molecular syndromology
2025

Case report: Diagnosis of a double aortic arch in the primary care setting.

Journal of family medicine and primary care
2025

Heterogeneity of Orodental Features in a Family with Noonan Syndrome.

International journal of molecular sciences
2025

Sternotomy healing by secondary intention in a complex single ventricle patient after stage 1 palliation.

Journal of cardiothoracic surgery
2026

Generation of three induced pluripotent stem cell clones from a functional single ventricle patient carrying the BRAF c.1897 T > C variant.

Stem cell research
2025

Volume Loading May Compromise Left Ventricular Filling in Patients with a Borderline Hypoplastic Left Ventricle.

International heart journal
2025

Co-Occurrence of Urogenital Anomalies and Congenital Heart Disease in a Child With Alpha-Thalassemia Mental Retardation Syndrome Associated With Chromosome 16 Abnormalities due to Partial Monosomy 16p13.3 and Partial Trisomy 16q22.1-q24.3.

Congenital anomalies
2025

A Novel STAG2 Frameshift Variant in Mullegama-Klein-Martinez Syndrome with Complex Conotruncal Heart Defect.

Genes
2025

Incidence and multisystem preadolescent complications of Turner syndrome: a nationwide study.

Pediatrics and neonatology
2026

Macular and optic nerve hypoplasia in chromosome 2p partial trisomy.

Ophthalmic genetics
2025

Approach to prolonged QT interval in paediatric and neonatal patients.

European journal of pediatrics
2026

De novo truncating variant in the FBRSL1 gene caused neurodevelopmental disorders, epilepsy, congenital heart disease, and facial dysmorphism.

Experimental neurology
2025

Clinical and Genetic Characterization of Noonan Syndrome in a Romanian Cohort from Transylvania: Details on PTPN11 c.922A>G Variant and Phenotypic Spectrum.

Diagnostics (Basel, Switzerland)
2025

Are NONO variants linked to congenital heart disease? Patient reports and review.

European journal of medical genetics
2025

Door-to-Balloon Time Delay in Complex Primary Angioplasty: A Case of Anomalous Origin of the Right Coronary Artery From the Pulmonary Artery (ARCAPA).

Case reports in cardiology
2025

Barth syndrome: Natural history in infants and young children.

Molecular genetics and metabolism
2025

Mexican Patients With Suspected 22q11.2 Deletion Syndrome: Clinical Characterization and Molecular Findings by Fluorescence In Situ Hybridization and Multiplex Ligation-Dependent Probe Amplification.

Molecular genetics &amp; genomic medicine
2025

Comprehensive prenatal and postnatal analysis of 22q11.2 microdeletion syndrome: a single-center study.

BMC pregnancy and childbirth
2025

Progressive hypergonadotropic hypogonadism in an adolescent with 22q11.2 deletion syndrome.

BMC endocrine disorders
2026

Non-RASopathy Genetic Syndromes Identified as the Molecular Cause of Disease in Patients Previously Diagnosed With Noonan Syndrome.

American journal of medical genetics. Part A
2026

De Novo Heterozygous ZFX Frameshift Variant in a Female With an X-Linked Neurodevelopmental Disorder.

American journal of medical genetics. Part A
2025

A cardiovascular, craniofacial, and neurodevelopmental disorder caused by loss-of-function variants in the eIF3 complex component genes EIF3A and EIF3B.

American journal of human genetics
2025

Myocardial Infarction in a Young Adult: A Rare Case of Left Coronary Artery Arising from the Pulmonary Artery.

Life (Basel, Switzerland)
2025

Surgical repair of Laubry-Pezzi syndrome with aortic root dilatation in two adult patients: Case reports from Benin.

International journal of surgery case reports
2025

Parietal Lobe Epilepsy Associated With 2q13 Duplication: Expanding the Neurogenetic Spectrum.

Cureus
2025

Noonan Syndrome With Complex Pulmonary Stenosis at High Altitude: Impact of Delayed Diagnosis.

JACC. Case reports
2026

Bi-allelic INTU variants define a ciliopathy disorder characterized by orofacial, digital, and cardiac anomalies.

HGG advances
2025

Amplitude-Integrated/Continuous Electroencephalography for Early Detection of Low Cardiac Output After Chest Closure in an Infant.

JACC. Case reports
2025

Noonan syndrome with PTPN11 gene variant presenting as isolated short stature: a case report.

Translational pediatrics
2026

Routine Primary Sternal Closure After the Norwood Procedure.

World journal for pediatric &amp; congenital heart surgery
2025

The deficiency of DIP2C leads to congenital heart defects in patients with 10p15.3 microdeletion syndrome.

Gene
2025

A Case of CHARGE Syndrome with a Novel Intronic Variant in the CHD7 Gene.

Journal of clinical research in pediatric endocrinology
2025

Sternal opening width is associated with increased risk for capillary leak syndrome and death in neonates and infants after cardiac surgery with delayed sternal closure.

Cardiology in the young
2025

Identification of a novel de novo AFF4 variant (c.778A>G) associated with CHOPS syndrome.

Intractable &amp; rare diseases research
2025

Surviving trisomy 18: A case report of a 5-year-old girl.

Medicine
2025

A change of heart: the evolution of care for children with Trisomy 21 and CHD.

Cardiology in the young
2025

Dandy-Walker Syndrome and Congenital Heart Defects in a Child: A Case Report.

Radiology case reports
2025

Parental experiences and needs in Kleefstra Syndrome: A semi-structured interview study.

European journal of medical genetics
2025

A 25-year single-center study on Kawasaki disease in the Polish population: Insights into long-term outcomes and coronary complications.

Kardiologia polska
2025

Prenatal Characterization of Houge-Janssens Syndrome Type 2: A Case Report and Systematic Review of Fetal Phenotypes Associated With PPP2R1A Mutations.

Molecular genetics &amp; genomic medicine
2025

Technical considerations and long-term outcomes of successful one-stage repair of Berry syndrome in a preterm neonate using deep hypothermic circulatory arrest: A case report.

International journal of surgery case reports
2025

Extremely Rare Neonatal Case With Pyloric Atresia, Heart Defects, Hypotonia, Jaundice, and Acidosis.

Clinical case reports
2025

Expanding the phenotypic spectrum of Beaulieu-Boycott-Innes syndrome: A case report of a novel THOC6 gene mutation associated with ambiguous genitalia and disorders of sexual development.

Medicine
2025

mRNA Expression to Assess Hypoxia and Angiogenesis in Decidual Tissue of Term Fetuses With a Congenital Heart Disease.

Prenatal diagnosis
2025

Expanding the Phenotypic Spectrum Associated with DPH5-Related Diphthamide Deficiency.

Genes
2025

Snijders Blok-Campeau Syndrome Associated with Pulmonary Arterial Hypertension: A Case Report.

Reports (MDPI)
2025

The Diagnostic Value of Copy Number Variants in Genetic Cardiomyopathies and Channelopathies.

Journal of cardiovascular development and disease
2025

Identification of variants in SWI/SNF complex genes associated with neurodevelopmental disorders.

Frontiers in genetics
2025

[Cardiofaciocutaneous syndrome caused by microdeletion of chromosome 19p13.3: a case report and literature review].

Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics
2025

Fork Stalling and Template Switching in a Complex der(6)dn with Duplication of 6q24.3qter and 6p25.3: A Case Report.

Cytogenetic and genome research
2025

A novel heterozygous mutation of ANKRD11 causes KBG syndrome in a preterm neonate: a case report and literature review.

Frontiers in pediatrics
2025

Role of Histopathology of Skin Lesions in Diagnosing MAP2K1-Positive Cardiofaciocutaneous Syndrome.

The American Journal of dermatopathology
2026

First Report of a Novel ZNF462 Variant Linked to Weiss-Kruszka Syndrome and Congenital Diaphragmatic Hernia: Insights into Potential Additional Malformations.

Molecular syndromology
2025

ZNF280A links DNA double-strand break repair to human 22q11.2 distal deletion syndrome.

Nature cell biology
2025

Rehabilitation in a child with Chiari II malformation, lumbosacral meningomyelocele, achondroplasia and impaired respiratory regulation - a case report and literature review.

Journal of pediatric rehabilitation medicine
2025

CHARGE Syndrome in a Six-Month-Old Male Infant: A Case Report.

Cureus
2025

[Clinical and genetic investigation of 4 children with microdeletion KBG syndrome].

Zhonghua er ke za zhi = Chinese journal of pediatrics
2025

Congenital Rubella Syndrome in the Post-Elimination Era: Why Vigilance Remains Essential.

Journal of clinical medicine
2025

"Bubbly heart," a case report of Morgagni hernia delayed diagnosis in patient with Down syndrome: The hernia is in the details.

Radiology case reports
2025

Acquired feeding difficulties in infants after on-pump cardiac surgery: A single-center retrospective cohort study.

Pediatrics international : official journal of the Japan Pediatric Society
2025

Variable expressivity of a transmitted pathogenic KAT6B variant.

European journal of medical genetics
2025

Age-Related Dysphagia Among Children with 22q11.2-Deletion Syndrome.

The Cleft palate-craniofacial journal : official publication of the American Cleft Palate-Craniofacial Association
2025

Phenotypic Spectrum of KATNIP-Associated Joubert Syndrome: Possible Association with Esophageal Atresia and Review of the Literature.

Genes
2025

KDM2B variants in the CxxC domain impair its DNA-binding ability and cause a distinct neurodevelopmental syndrome.

Human molecular genetics
2025

Truncating Variants in RREB1 Cause a Novel RASopathy Syndrome of Congenital Heart Disease, Genitourinary Malformations, and Developmental Delay.

American journal of medical genetics. Part A
2025

A new association between Kleefstra syndrome and Panayiotopoulos epilepsy.

Italian journal of pediatrics
2025

[Clinical analysis of a child with heterotopic ventricular gray matter Renpenning syndrome caused by PQBP1 gene mutation and a literature review].

Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics
2025

Outcomes and Predictors of Failure of Systemic-to-Pulmonary Shunts: Experience of a Single Institution Over 14 Years.

World journal for pediatric &amp; congenital heart surgery
2025

Short-Term Results of Early Detection of Critical Congenital Heart Disease: The Peruvian Maternal Perinatal Experience.

JACC. Advances
2025

Outcomes of pediatric mild sleep-disordered breathing.

Sleep medicine
2025

Update on the Clinical and Molecular Characterization of Noonan Syndrome and Other RASopathies: A Retrospective Study and Systematic Review.

International journal of molecular sciences
2025

Long term follow-up of multiorgan disease in Kleefstra syndrome 2 in an adult - case report.

BMC neurology
2025

Compound Heterozygous MRPS14 Variants Associated With Leigh Syndrome.

Annals of clinical and translational neurology
2025

Dual Diagnosis of Sifrim-Hitz-Weiss Syndrome and Neurofibromatosis Type 1: Expanding the Phenotype of Cardiac Features in Sifrim-Hitz-Weiss Syndrome and Quick Literature Review.

American journal of medical genetics. Part A
2026

The Timing and Factor of Ductus Arteriosus Closure in Infants with Down Syndrome Born at Term and Late-Preterm.

Pediatric cardiology
2025

Homozygous variants in EIF3K associated with neurodevelopmental delay, microcephaly, and growth retardation.

HGG advances
2025

131-Radioiodine Therapy for Graves Disease in a Patient With Down Syndrome and Non-operable Congenital Heart Disease.

Cureus
2025

Complete Atrioventricular Septal Defect Repair in Patients With Down Syndrome Presenting Beyond Six Months- A Single Center Experience.

World journal for pediatric &amp; congenital heart surgery
2025

Congenital heart disease presentations in the 15q11.2 microdeletion syndrome.

Frontiers in genetics
2025

Turner syndrome: the promise of fertility via stem cell technology.

Hormones (Athens, Greece)
2025

Hyaluronidase 2 deficiency due to novel compound heterozygous variants in HYAL2: a case report of siblings with HYAL2 deficiency showing different clinical severity and literature review.

Journal of human genetics
2025

High Altitude May Protect Against the Early Development of Irreversible Pulmonary Hypertension in Patients With Congenital Heart Disease.

Pulmonary circulation
2025

Genomic analysis of 11,555 probands identifies 60 dominant congenital heart disease genes.

Proceedings of the National Academy of Sciences of the United States of America
2025

Delayed Diagnosis of Partial Anomalous Pulmonary Venous Return in an Adult With Pulmonary Hypertension.

Journal of investigative medicine high impact case reports
2025

Bi-allelic MED16 variants cause a MEDopathy with intellectual disability, motor delay, and craniofacial, cardiac, and limb malformations.

American journal of human genetics
2025

Prevalence, Risk Factors, and Outcomes of Hospital-Acquired Infections in Children After Congenital Heart Surgery.

World journal for pediatric &amp; congenital heart surgery
2025

Neonatal lupus erythematosus: an acquired autoimmune disease to be taken seriously.

Annals of medicine
2025

Neonatal lupus erythematosus presenting with congenital heart block: clinical characteristics and follow-up.

Clinical rheumatology
2025

[Clinical features of CHARGE syndrome in children].

[Zhonghua yan ke za zhi] Chinese journal of ophthalmology
2025

De Novo Deletion in the 12q24.23q24.31 Chromosomal Region Causing a Neurodevelopmental Syndrome in a Female Saudi Patient: A Case Report.

Cureus
2025

Maternal Phenylketonuria: Consequences of Dietary Non-Adherence and Gaps in Preconception Care-A Case Report.

Journal of clinical medicine
2025

[Duplication of the X-chromosomal Xq28 region containing the MECP2 gene in X-linked intellectual disability syndrome Lubs-type].

Orvosi hetilap
2025

Establishment of a human induced pluripotent stem cell line, KMUGMCi008-A, from a patient with A Say-Barber-Biesecker-Young-Simpson variant of Ohdo syndrome bearing heterozygous frameshift mutation in the KAT6B gene.

Stem cell research
2025

Unmasking a Recessive Allele by a Rare Interstitial Deletion at 10q26.13q26.2: Prenatal Diagnosis of MMP21 -Related Disorder and Further Refine INSYN2A Involvement in the Postnatal Cognitive Phenotype.

Molecular genetics &amp; genomic medicine
2025

Evaluation of Integrated Service Strategy Based on Diagnosis of Duct-Dependent Congenital Heart Disease and Neonatal Mortality Data Analysis - Beijing, China, 2021-2022.

China CDC weekly
2025

Kabuki and CHARGE syndromes: overlapping symptoms and diagnostic challenges.

Einstein (Sao Paulo, Brazil)
2025

Comprehensive review and outline of genotypes and phenotypes of Arboleda-Tham syndrome spectrum: insights from novel variants.

Molecular biology reports
2025

Peripandemic outcomes of infants treated for sentinel congenital heart diseases in England and Wales.

Open heart
2025

A Novel Truncating Variant in Sandestig-Stefanova Syndrome with Hydrocephalus.

Molecular syndromology
2025

Neurodevelopmental Outcomes After Nitric Oxide During Cardiopulmonary Bypass for Open Heart Surgery: A Randomized Clinical Trial.

JAMA network open
2024

Impact of pubertal timing on growth progression and final height in subjects affected by RASopathies.

Frontiers in endocrinology
2025

Cerebral Microhemorrhages in Children With Congenital Heart Disease: Prevalence, Risk Factors, and Association With Neurodevelopmental Outcomes.

Journal of the American Heart Association
2025

A Novel Missense Mutation of the ABL1 Gene in a Child With Congenital Heart Defects and Skeletal Malformations Syndrome.

American journal of medical genetics. Part A
2025

Expanding the clinical spectrum of 19p13.3 microduplication syndrome: a case report highlighting nephrotic syndrome and literature review.

BMC pediatrics
2025

Comorbidities and Healthcare Utilization Among Young Adults With Congenital Heart Defects by Down Syndrome Status-Congenital Heart Survey to Recognize Outcomes, Needs, and wellbeinG, 2016-2019.

Birth defects research
2024

Case Report: Craniofacial deafness hand syndrome with unusual cardiovascular symptoms and lack of holistic care.

Frontiers in genetics
2025

Neurodevelopmental outcomes after infant heart surgery for congenital heart disease: a hospital-based multicentre prospective cohort study from India.

BMJ paediatrics open
2025

Jacobsen syndrome associated with Shone's complex: a case report.

Revista paulista de pediatria : orgao oficial da Sociedade de Pediatria de Sao Paulo
2025

[Growth and development patterns of Noonan syndrome and advances in the treatment of short stature].

Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics
2025

Validation of a hypomorphic variant in CDK13 as the cause of CHDFIDD with autosomal recessive inheritance through determination of an episignature.

Clinical epigenetics
2025

Maternal autoimmune systemic connective tissue disease and vasculitis and electrocardiographic findings in the offspring.

Journal of autoimmunity
2025

Long read Nanopore sequencing identifies precise breakpoints of a de novo paracentric inversion that disrupt the MEIS2 gene in a Chinese girl with syndromic developmental delay.

BMC pediatrics
2025

Double Outlet Right Ventricle: A Rare Finding in a 15-Month-Old Female With Failure to Thrive.

Clinical case reports
2024

[DiGeorge syndrome with 22q11.2 deletion in a patient of Rarámuri ethnicity].

Revista alergia Mexico (Tecamachalco, Puebla, Mexico : 1993)
2025

Identification of de-novo CREBBP gene variants in patients with Rubinstein-Taybi syndrome.

Psychiatric genetics
2025

Baricitinib Treatment in RNU7-1-Associated Aicardi-Goutières Syndrome in a South African Child: A Case Report.

American journal of medical genetics. Part A
2025

Novel Phenotypes and Genotype-Phenotype Correlations in a Large Clinical Cohort of Patients With Kleefstra Syndrome.

Clinical genetics
2025

From growth hormone deficiency to Kleefstra-2 syndrome: diagnostic  reassessment of treatment-refractory short stature.

Pediatric endocrinology, diabetes, and metabolism
2024

Surgical treatment experience of seven cases of Berry syndrome.

Journal of cardiothoracic surgery
2025

NONO-related X-linked intellectual disability syndrome: Further clinical and molecular delineation.

European journal of medical genetics
2024

Clinical characteristics and genetic analysis of four pediatric patients with Kleefstra syndrome.

BMC medical genomics
2025

Novel risk predictor of arrhythmias for patients with potassium channel-related congenital long QT syndrome.

Heart rhythm
2024

Transcatheter intervention of modified Blalock-Taussig shunts in patients with hypoplastic left heart syndrome undergoing stage 1 palliation.

Frontiers in cardiovascular medicine
2025

MGA-related syndrome: A proposed novel disorder.

HGG advances
2024

Noonan Syndrome: Relation of Genotype to Cardiovascular Phenotype-A Multi-Center Retrospective Study.

Genes
2024

Antidepressant exposure patterns during pregnancy and risk of adverse newborn outcomes.

Psychiatry research
2025

Motor proficiency in school-aged children with CHD.

Cardiology in the young
2025

Cyclin-dependent kinase 13 is indispensable for normal mouse heart development.

Journal of anatomy
2024

20p chromosome inverted duplication syndrome with phenotypes of congenital heart disease, anorectal malformation and megacolon.

BMJ case reports
2024

Accidental finding of ALCAPA in a child with severe mitral regurgitation: A case study.

Asian cardiovascular &amp; thoracic annals
2024

Uncommon presentation: monozygotic twins with Turner syndrome.

BMJ case reports
2024

Successful Anesthetic Management of a Pediatric Patient With Wolf-Hirschhorn Syndrome Undergoing Strabismus Surgery: A Case Report.

Cureus
2024

Impact of Persistent Pulmonary Hypertension of the Newborn in Neonates with Dextro-transposition of the Great Arteries.

Journal of cardiothoracic and vascular anesthesia
2024

Phenotype of patients with late diagnosis of 22q11 deletion: a review and retrospective study.

Internal medicine journal
2025

Comparing Parent Perception of Neurodevelopment after Primary versus Staged Repair of Neonatal Symptomatic Tetralogy of Fallot.

The Journal of pediatrics
2024

Validation of a Paralimbic-Related Subcortical Brain Dysmaturation MRI Score in Infants with Congenital Heart Disease.

Journal of clinical medicine
2024

Bronchial Atresia with Eisenmenger Syndrome in a Complex Congenital Heart Disease-A Rare Coexistence: A Case Report.

The Journal of the Association of Physicians of India
2024

2q31 microdeletion syndrome with the velocardiofacial phenotype and review of the literature: a case report.

BMC pediatrics
2024

Identification of a Novel Frameshift variant of the ATRX gene: a Case Report and Review of the genotype-phenotype relationship.

BMC pediatrics
2024

"An update on the approach to treatment of Sjogren's Disease in pregnancy".

The journal of maternal-fetal &amp; neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians
2024

Biventricular Hypertrophic Cardiomyopathy in a 26-year-old Nigerian Woman with Noonan Syndrome.

West African journal of medicine
2024

Phenome-wide profiling identifies genotype-phenotype associations in Phelan-McDermid syndrome using family-sourced data from an international registry.

Molecular autism
2024

HDR syndrome presented with nephrotic syndrome in a Chinese boy: A case report.

World journal of clinical cases
2024

Exposure of Pregnancy to Pregestational Diabetes, Gestational Diabetes, and Antidiabetic Medications With Especial Focus on Major Congenital and Cardiac Malformations in Offspring.

The Journal of clinical psychiatry
2024

Missed opportunity in acute coronary syndrome.

BMJ case reports
2024

A phenome-wide association study of methylated GC-rich repeats identifies a GCC repeat expansion in AFF3 associated with intellectual disability.

Nature genetics
2024

A Rare Genetic Intersection: Down Syndrome With Coexisting Spinal Muscular Atrophy.

Cureus
2025

Seven Novel Variants of Weiss-Kruszka Syndrome and Phenotype Expansion.

American journal of medical genetics. Part A
2024

An expert rule-based approach for identifying infantile-onset Pompe disease patients using retrospective electronic health records.

Scientific reports
2024

Prenatal diagnosis of the recurrent 1q21.1 microdeletions in fetuses with ultrasound anomalies and review of the literature.

Frontiers in genetics
2024

Clinical phenotype of the 16p.13.11 microdeletion: a case report with a mini review of the literature.

Frontiers in genetics
2024

Genetic and Phenotypic Spectrum of KMT2D Variants in Taiwanese Case Series of Kabuki Syndrome.

Diagnostics (Basel, Switzerland)
2024

Splice site variants in the canonical donor site of MED13L exon 7 lead to intron retention in patients with MED13L syndrome.

Journal of medical genetics
2024

A nationwide survey of Vici syndrome in Japan.

Brain &amp; development
2024

Clinical Findings in a Series of Thirty Eight Patients with Williams-Beuren Syndrome.

Cytogenetic and genome research
2024

Phenotypic spectrum and tumor risk in Simpson-Golabi-Behmel syndrome: Case series and comprehensive literature review.

American journal of medical genetics. Part A
2024

7p22.3 microdeletion: a case study of a patient with congenital heart defect, neurodevelopmental delay and epilepsy.

Orphanet journal of rare diseases
2024

The first Brazilian clinical report of Kleefstra syndrome, including semicircular canals agenesis as a possible phenotype expansion.

European journal of medical genetics
2024

Septal Defects: Unveiling Sex-Based Disparities and Screening Challenges for Timely Intervention Through a Case Report and Systematic Literature Review.

Cureus
2024

A case report of spastic diplegic cerebral palsy in a late preterm child with hypoplastic left heart syndrome.

Translational pediatrics
2024

SMC3 contributes to heart development by regulating super-enhancer associated genes.

Experimental &amp; molecular medicine
2024

Placenta histology related to flow and oxygenation in fetal congenital heart disease.

Early human development
2025

Multidisciplinary Velopharyngeal Dysfunction Evaluation Helps Detect Non-classic Cases of 22q11.2 Deletion.

The Cleft palate-craniofacial journal : official publication of the American Cleft Palate-Craniofacial Association
2024

Infant of a diabetic mother: clinical presentation, diagnosis and treatment.

Pediatric endocrinology, diabetes, and metabolism
2024

Beneficial normalization of cardiac repolarization by carnitine in transgenic short QT syndrome type 1 rabbit models.

Cardiovascular research
2024

Pathogenic variants in KMT2C result in a neurodevelopmental disorder distinct from Kleefstra and Kabuki syndromes.

American journal of human genetics
2024

Trichohepatoenteric syndrome type 1: expanding the clinical spectrum of THES type 1 due to a homozygous variant in the SKIC3 gene.

BMC pediatrics
2023

Phenotypic and cytogenetic variability of patau syndrome in Morocco.

African health sciences
2024

Using a new analytic approach for genotyping and phenotyping chromosome 9p deletion syndrome.

European journal of human genetics : EJHG
2025

First report of Coffin-Siris Syndrome with SMARCB1 variant, normal intelligence and mild selective neuropsychological deficits: A case report and literature review.

The Clinical neuropsychologist
2024

Nerve enlargement in patients with Noonan syndrome: A retrospective cohort study.

American journal of medical genetics. Part A
2024

Primary surgical repair of tetralogy of fallot at the Uganda Heart Institute: a ten-year review of 30day mortality and morbidity.

BMC cardiovascular disorders
2024

Idiopathic pulmonary hemosiderosis associated with Kabuki syndrome.

Immunological medicine
2024

How do we treat severely prolapsed true ectopia cordis?

European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery

Associações

Organizações que acompanham esta doença — pra ter apoio e orientação

Ainda não temos associações cadastradas para Síndrome de anomalia cardíaca congênita-dismorfia facial-transtorno do desenvolvimento TMEM94-associada.

É de uma associação que acompanha esta doença? Fale com a gente →

Comunidades

Grupos ativos de quem convive com esta doença aqui no Raras

Ainda não existe comunidade no Raras para Síndrome de anomalia cardíaca congênita-dismorfia facial-transtorno do desenvolvimento TMEM94-associada

Pacientes, familiares e cuidadores se organizam em comunidades pra compartilhar experiências, fazer perguntas e se apoiar. Você pode ser o primeiro.

Tire suas dúvidas

Perguntas, dicas e experiências compartilhadas aqui na página

Participe da discussão

Faça login para postar dúvidas, compartilhar experiências e interagir com especialistas.

Fazer login

Doenças relacionadas

Doenças com sintomas parecidos — ajudam quem ainda está buscando diagnóstico

Ordenadas pelo número de sintomas em comum.

Referências e fontes

Bases de dados externas citadas neste artigo

Publicações científicas

Artigos indexados no PubMed ligados a esta doença no grafo RarasNet — título, periódico e PMID direto da fonte, sem intermediação de IA.

  1. Inferior wall ST-elevation myocardial infarction in a patient with a single coronary artery from the right coronary cusp trifurcating into the left anterior descending, left circumflex, and right coronary arteries: a rare coronary anomaly, case report.
    European heart journal. Case reports· 2026· PMID 41877722mais citado
  2. Acute Coronary Syndromes in Premenopausal Women: A Scientific Statement From the American Heart Association.
    Circulation· 2026· PMID 41631393mais citado
  3. Expanding the Phenotypic Spectrum Associated With Loss-of-Function SMARCA4 Variants to Eye Developmental Anomalies.
    Clinical genetics· 2026· PMID 41568967mais citado
  4. Generation of three induced pluripotent stem cell clones from a functional single ventricle patient carrying the BRAF c.1897&#xa0;T&#xa0;&gt;&#xa0;C variant.
    Stem cell research· 2026· PMID 41349284mais citado
  5. De novo truncating variant in the FBRSL1 gene caused neurodevelopmental disorders, epilepsy, congenital heart disease, and facial dysmorphism.
    Experimental neurology· 2026· PMID 41232796mais citado
  6. Long read Nanopore sequencing identifies precise breakpoints of a de novo paracentric inversion that disrupt the MEIS2 gene in a Chinese girl with syndromic developmental delay.
    BMC Pediatr· 2025· PMID 39789493recente
  7. Surgical treatment experience of seven cases of Berry syndrome.
    J Cardiothorac Surg· 2024· PMID 39736764recente
  8. MGA-related syndrome: A proposed novel disorder.
    HGG Adv· 2025· PMID 39600096recente
  9. Expanding phenotype of MED13-associated syndrome presenting novel de novo missense variant in a patient with multiple congenital anomalies.
    BMC Med Genomics· 2024· PMID 38745205recente
  10. Syndromic craniosynostosis caused by a novel missense variant in MAP4K4: Expanding the genotype-phenotype relationship in RASopathies.
    Clin Genet· 2024· PMID 38679877recente

Bases de dados e fontes oficiais

Identificadores e referências canônicas usadas para montar este verbete.

  1. ORPHA:562569(Orphanet)
  2. OMIM OMIM:618316(OMIM)
  3. MONDO:0032672(MONDO)
  4. GARD:17998(GARD (NIH))
  5. Variantes catalogadas(ClinVar)
  6. Busca completa no PubMed(PubMed)

Dados compilados pelo RarasNet a partir de fontes abertas (Orphanet, OMIM, MONDO, PubMed/EuropePMC, ClinicalTrials.gov, DATASUS, PCDT/MS). Este conteúdo é informativo e não substitui avaliação médica.

Conteúdo mantido por Agente Raras · Médicos e pesquisadores podem colaborar

Compêndio · Raras BR

Síndrome de anomalia cardíaca congênita-dismorfia facial-transtorno do desenvolvimento TMEM94-associada

ORPHA:562569 · MONDO:0032672
Prevalência
<1 / 1 000 000
Casos
10 casos conhecidos
Herança
Autosomal recessive
CID-10
Q87.8 · Outras síndromes com malformações congênitas especificadas, não classificadas em outra parte
CID-11
Início
Antenatal, Neonatal
Prevalência
0.0 (Worldwide)
MedGen
UMLS
C5193024
DiscussaoAtiva

Nenhuma novidade ainda. O agente esta monitorando.

0membros
0novidades